









Markets
/
Stocks
/
nasdaq-bhst
/

Bioharvest Sciences Inc

BHST

8.960USD

+0.255+2.93%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

155.31MMarket Cap

LossP/E TTM



Bioharvest Sciences Inc

8.960

+0.255+2.93%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

41 / 102

Overall Ranking

186 / 4720

Industry

Food & Tobacco

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Buy

Current Rating

14.750

Target Price

+69.44%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 358.13% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 25.19M.

Undervalued

The company’s latest PE is -13.08, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 4.61M shares, increasing 0.22% quarter-over-quarter.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.68, which is lower than the Food & Tobacco industry's average of 7.03. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 8.52M, representing a year-over-year increase of 41.28%, while its net profit experienced a year-over-year increase of 493.89%.

Score

Industry at a Glance

Previous score

6.68

Change



Financials

4.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

5.94

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.04

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.25

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 4.00, which is lower than the Food & Tobacco industry's average of 5.38. Its current P/E ratio is -12.71, which is -43.16% below the recent high of -7.23 and -1.22% above the recent low of -12.87.

Score

Industry at a Glance

Previous score

4.00

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 41/102

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 8.00, which is higher than the Food & Tobacco industry's average of 7.40. The average price target for Bioharvest Sciences Inc is 14.50, with a high of 18.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Buy

Current Rating

14.750

Target Price

+69.44%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Bioharvest Sciences Inc

BHST

Mondelez International Inc

MDLZ

Hershey Co

HSY

Kraft Heinz Co

KHC

Campbell's Co

CPB

General Mills Inc

GIS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 9.18, which is higher than the Food & Tobacco industry's average of 6.67. Sideways: Currently, the stock price is trading between the resistance level at 10.04 and the support level at 6.93, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.18

Change

0.15

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.234

Buy

RSI(14)

58.253

Neutral

STOCH(KDJ)(9,3,3)

76.431

Neutral

ATR(14)

0.663

High Vlolatility

CCI(14)

85.179

Neutral

Williams %R

20.579

Buy

TRIX(12,20)

0.003

Sell

StochRSI(14)

41.511

Neutral

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

8.893

Buy

MA10

8.243

Buy

MA20

8.183

Buy

MA50

8.064

Buy

MA100

7.390

Buy

MA200

6.618

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Rakib (Vivien)

3.03M

+0.72%

Greensoil Investments Management Ltd

1.42M

Magnus Financial Group LLC

71.73K

+104.95%

Ryan (David K)

39.01K

True North Advisors, LLC

44.39K

+7.56%

TD Waterhouse Canada, Inc.

12.04K

Binder (Anne)

8.96K

Moreh (Bar)

1.15K

Osaic Holdings, Inc.

628.00

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 2.50, which is lower than the Food & Tobacco industry's average of 4.35. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.